Free Trial

Transcat (TRNS) Competitors

Transcat logo
$86.28 +3.02 (+3.63%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$86.37 +0.09 (+0.10%)
As of 04/15/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TRNS vs. ST, CAMT, TXG, CTKB, LAB, SENS, ALNT, EYPT, AEHR, and QSI

Should you be buying Transcat stock or one of its competitors? The main competitors of Transcat include Sensata Technologies (ST), Camtek (CAMT), 10x Genomics (TXG), Cytek Biosciences (CTKB), Standard BioTools (LAB), Senseonics (SENS), Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), and Quantum-Si (QSI). These companies are all part of the "measuring and control equipment" industry.

Transcat vs.

Transcat (NASDAQ:TRNS) and Sensata Technologies (NYSE:ST) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability, dividends and community ranking.

Transcat has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Comparatively, Sensata Technologies has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.

In the previous week, Sensata Technologies had 11 more articles in the media than Transcat. MarketBeat recorded 18 mentions for Sensata Technologies and 7 mentions for Transcat. Transcat's average media sentiment score of 1.71 beat Sensata Technologies' score of 0.26 indicating that Transcat is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Transcat
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Sensata Technologies
2 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral

98.3% of Transcat shares are held by institutional investors. Comparatively, 99.4% of Sensata Technologies shares are held by institutional investors. 2.3% of Transcat shares are held by insiders. Comparatively, 1.0% of Sensata Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Transcat has a net margin of 6.22% compared to Sensata Technologies' net margin of 3.27%. Sensata Technologies' return on equity of 17.54% beat Transcat's return on equity.

Company Net Margins Return on Equity Return on Assets
Transcat6.22% 7.23% 5.67%
Sensata Technologies 3.27%17.54%6.86%

Sensata Technologies received 238 more outperform votes than Transcat when rated by MarketBeat users. However, 66.14% of users gave Transcat an outperform vote while only 61.76% of users gave Sensata Technologies an outperform vote.

CompanyUnderperformOutperform
TranscatOutperform Votes
211
66.14%
Underperform Votes
108
33.86%
Sensata TechnologiesOutperform Votes
449
61.76%
Underperform Votes
278
38.24%

Transcat currently has a consensus target price of $111.50, suggesting a potential upside of 29.23%. Sensata Technologies has a consensus target price of $35.55, suggesting a potential upside of 80.21%. Given Sensata Technologies' higher probable upside, analysts clearly believe Sensata Technologies is more favorable than Transcat.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Transcat
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Sensata Technologies
1 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.36

Sensata Technologies has higher revenue and earnings than Transcat. Sensata Technologies is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Transcat$272.20M2.95$13.65M$1.8546.64
Sensata Technologies$3.93B0.75$128.48M$0.8423.48

Summary

Sensata Technologies beats Transcat on 10 of the 18 factors compared between the two stocks.

Remove Ads
Get Transcat News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRNS vs. The Competition

MetricTranscatInstruments to measure electricity IndustryComputer SectorNASDAQ Exchange
Market Cap$803.18M$3.75B$22.17B$7.57B
Dividend YieldN/A0.58%3.01%4.32%
P/E Ratio46.6419.9039.4917.82
Price / Sales2.952.221,985.9694.61
Price / Cash27.1417.8734.6334.64
Price / Book2.863.005.774.00
Net Income$13.65M$135.28M$736.02M$247.23M
7 Day Performance12.73%-1.07%0.76%1.45%
1 Month Performance18.89%-6.93%-5.36%-6.24%
1 Year Performance-20.52%-14.79%52,780.55%0.60%

Transcat Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRNS
Transcat
2.6643 of 5 stars
$86.28
+3.6%
$111.50
+29.2%
-21.6%$803.18M$272.20M46.64920News Coverage
Positive News
ST
Sensata Technologies
4.8246 of 5 stars
$18.87
+0.8%
$38.00
+101.4%
-41.9%$2.82B$3.93B22.4620,800Analyst Forecast
High Trading Volume
CAMT
Camtek
4.1165 of 5 stars
$55.17
+9.1%
$110.22
+99.8%
-23.1%$2.52B$429.23M22.80400Analyst Downgrade
Positive News
TXG
10x Genomics
4.5422 of 5 stars
$7.58
+1.5%
$20.21
+166.7%
-75.2%$927.05M$610.79M-4.991,240
CTKB
Cytek Biosciences
1.8264 of 5 stars
$3.67
-1.1%
$6.42
+74.8%
-38.2%$470.12M$200.45M-45.87500Short Interest ↑
Gap Down
LAB
Standard BioTools
2.8917 of 5 stars
$1.10
+2.8%
$2.50
+127.3%
-58.5%$416.89M$174.43M-1.55620Gap Down
SENS
Senseonics
1.7106 of 5 stars
$0.56
-3.0%
$2.00
+260.1%
+38.3%$362.04M$22.47M-4.2790
ALNT
Allient
4.3725 of 5 stars
$20.45
+0.4%
$31.00
+51.6%
-32.4%$346.59M$529.97M23.241,950Positive News
EYPT
EyePoint Pharmaceuticals
1.5265 of 5 stars
$4.62
+0.2%
$26.63
+476.3%
-73.4%$317.53M$43.27M-2.31120Positive News
AEHR
Aehr Test Systems
3.7898 of 5 stars
$7.22
-0.6%
$25.00
+246.3%
-26.1%$214.52M$50.74M9.6390Analyst Revision
QSI
Quantum-Si
1.9773 of 5 stars
$1.14
+0.9%
$3.48
+204.8%
-25.9%$208.78M$3.06M-1.78150Short Interest ↑
Remove Ads

Related Companies and Tools


This page (NASDAQ:TRNS) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners